116 related articles for article (PubMed ID: 16753449)
1. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease.
Hellstrom WJ; Kendirci M; Matern R; Cockerham Y; Myers L; Sikka SC; Venable D; Honig S; McCullough A; Hakim LS; Nehra A; Templeton LE; Pryor JL
J Urol; 2006 Jul; 176(1):394-8. PubMed ID: 16753449
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of non-surgical management in Peyronie's disease.
Hayat S; Brunckhorst O; Alnajjar HM; Cakir OO; Muneer A; Ahmed K
Int J Impot Res; 2023 Sep; 35(6):523-532. PubMed ID: 36289392
[TBL] [Abstract][Full Text] [Related]
3. Current trends in non-surgical management of Peyronie's disease-A narrative review.
Kozub A; Suleja A; Chłosta M; Kupilas A; Pradere B; Rivas JG; Rajwa P; Miszczyk M
Andrology; 2024 Mar; 12(3):505-517. PubMed ID: 37593783
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of verapamil efficacy in Peyronie's disease comparing with pentoxifylline.
Alizadeh M; Karimi F; Fallah MR
Glob J Health Sci; 2014 Sep; 6(7 Spec No):23-30. PubMed ID: 25363175
[TBL] [Abstract][Full Text] [Related]
5. Safety and feasibility of percutaneous needle tunneling with platelet-rich plasma injections for Peyronie's disease in the outpatient setting: a pilot study.
Zugail AS; Alshuaibi M; Lombion S; Beley S
Int J Impot Res; 2024 Apr; 36(2):140-145. PubMed ID: 37550385
[TBL] [Abstract][Full Text] [Related]
6. Medical Treatment for Peyronie's Disease: Systematic Review and Network Bayesian Meta-Analysis.
Lee HY; Pyun JH; Shim SR; Kim JH
World J Mens Health; 2024 Jan; 42(1):133-147. PubMed ID: 37382281
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Pirfenidone on Peyronie Plaques and Erectile Function in a Peyronie's Rat Model.
Cevik G; Tozsin A; Tastekin E; Dursun M; Aktoz T; Kadioglu A
J Coll Physicians Surg Pak; 2023 Nov; 33(11):1217-1222. PubMed ID: 37926870
[TBL] [Abstract][Full Text] [Related]
8. Tadalafil once daily and intralesional verapamil injection: A new therapeutic direction in Peyronie's disease.
Dell'Atti L
Urol Ann; 2015; 7(3):345-9. PubMed ID: 26229323
[TBL] [Abstract][Full Text] [Related]
9. Role of extracorporeal shock wave therapy in management of Peyronie's disease: A preliminary report.
Shimpi RK; Jain RJ
Urol Ann; 2016; 8(4):409-417. PubMed ID: 28057983
[TBL] [Abstract][Full Text] [Related]
10. Commentary on "Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's disease: a retrospective cohort study".
Manfredi C; Bologna E; Licari LC
Int J Impot Res; 2024 Apr; 36(2):166-167. PubMed ID: 38110571
[No Abstract] [Full Text] [Related]
11. Intralesional interferon alpha-2b as a novel treatment for periocular squamous cell carcinoma in horses.
Martabano BB; Dow S; Chow L; Williams MMV; Mack MK; Bellone R; Wotman KL
PLoS One; 2024; 19(2):e0297366. PubMed ID: 38381740
[TBL] [Abstract][Full Text] [Related]
12. Expression of Concern: Comparison of Vitamin E and Propionyl-L-Carnitine, Separately or in Combination, in Patients With Early Chronic Peyronie's Disease: A Double-Blind, Placebo Controlled, Randomized Study.
Safarinejad MR; Hosseini SY; Kolahi AA
J Urol; 2023 Jan; ():101097JU0000000000003118. PubMed ID: 36626346
[No Abstract] [Full Text] [Related]
13. Review of Management Options for Patients With Atypical Peyronie's Disease.
Yafi FA; Hatzichristodoulou G; DeLay KJ; Hellstrom WJ
Sex Med Rev; 2017 Apr; 5(2):211-221. PubMed ID: 27544298
[TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness of Intralesional Therapy for Peyronie's Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis.
Russo GI; Cacciamani G; Cocci A; Kessler TM; Morgia G; Serefoglu EC; Albersen M; Verze P;
J Sex Med; 2019 Feb; 16(2):289-299. PubMed ID: 30692028
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.
Gelbard M; Goldstein I; Hellstrom WJ; McMahon CG; Smith T; Tursi J; Jones N; Kaufman GJ; Carson CC
J Urol; 2013 Jul; 190(1):199-207. PubMed ID: 23376148
[TBL] [Abstract][Full Text] [Related]
16. Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study.
Shirazi M; Haghpanah AR; Badiee M; Afrasiabi MA; Haghpanah S
Int Urol Nephrol; 2009; 41(3):467-71. PubMed ID: 19199072
[TBL] [Abstract][Full Text] [Related]
17. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.
Rehman J; Benet A; Melman A
Urology; 1998 Apr; 51(4):620-6. PubMed ID: 9586617
[TBL] [Abstract][Full Text] [Related]
18. Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study.
Gelbard MK; James K; Riach P; Dorey F
J Urol; 1993 Jan; 149(1):56-8. PubMed ID: 8417217
[TBL] [Abstract][Full Text] [Related]
19. Bibliometric analysis of most cited Peyronie's disease and its management publications.
Şahin MF; Doğan Ç; Akgül M; Yazıcı CM; Şeramet S; Dayısoylu HS
Front Surg; 2024; 11():1336391. PubMed ID: 38826812
[TBL] [Abstract][Full Text] [Related]
20. Conservative treatment of Peyronie's disease: a guide.
Cosentino M; Di Nauta M; Boeri L; Ferraioli G; Lucignani G; Ricapito A; Gadda F; Iafrate M; Mancini M; Dal Moro F; Ruiz-Castañe E; Bettocchi C; Montanari E; Sofikitis N
World J Urol; 2024 May; 42(1):317. PubMed ID: 38740620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
